Investors & Media
Breaking the Boundaries of Gene Therapy
Sio Gene Therapies is a clinical-stage company with a singular focus on pushing the boundaries of gene therapy to develop treatments for debilitating rare neurodegenerative diseases, including GM1 gangliosidosis and Tay-Sachs/Sandhoff disease.
Sio is leveraging its foundational scientific expertise built on decades of research, extensive collaborations with leading gene therapy institutes, and a flexible vector platform to liberate patients with debilitating diseases through the transformational power of gene therapies.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Site - All Releases
Events, Webcasts and Presentations
10.21.2021 8:30 AM EDT
Site - All Events
More information is coming soon.